Taiwan Semiconductor
TSM
Advanced Micro Devices
AMD
Alphabet-C
GOOG
Alphabet-A
GOOGL
NVIDIA
NVDA
US Stock MarketDetailed Quotes
MRSN Mersana Therapeutics
- 0.517
- +0.037+7.75%
Trading Mar 4 14:37 ET
64.46MMarket Cap-0.92P/E (TTM)
0.534High0.463Low4.42MVolume0.480Open0.480Pre Close2.27MTurnover5.61%Turnover RatioLossP/E (Static)124.63MShares6.28052wk High-6.81P/B40.77MFloat Cap0.46352wk Low--Dividend TTM78.83MShs Float29.090Historical High--Div YieldTTM14.90%Amplitude0.463Historical Low0.512Avg Price1Lot Size
Mersana Therapeutics Key Stats
EPS
According to the latest financial report of Mersana Therapeutics, the latest earnings per share (TTM) for the company is -0.11. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Mersana Therapeutics's free cash flow? The latest report shows it as -19.25M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Mersana Therapeutics shows that the company's current ratio is 2.19, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Mersana Therapeutics, the quick ratio is 2.16, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Mersana Therapeutics? The latest ROE figure is -242.74%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Mersana Therapeutics, the total asset return on investment (ROA) is -8.99%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Mersana Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Mersana Therapeutics, the net profit margin is -86.28%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.